The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties

被引:349
作者
Moosmann, B [1 ]
Behl, C [1 ]
机构
[1] Max Planck Inst Psychiat, D-80804 Munich, Germany
关键词
D O I
10.1073/pnas.96.16.8867
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Among the family of steroidal molecules, only estrogens have the capability of preventing neuronal cell death caused by increased oxidative burden. Employing neuronal cell lines, brain membrane, and low density lipoprotein oxidation assays, we show that the antioxidant and neuroprotective effects of estrogens are dependent not on their genomic properties as hormones but rather on their basic chemical properties as hydrophobic phenolic molecules, Concentrations of 17 beta-estradiol of 0.1-500 nM, which confer maximum estrogen receptor-dependent gene transcription in vitro as well as maximum estrogen receptor binding, respectively, do not show antioxidant or neuroprotective effects. In contrast, phenolic compounds such as 2,4,6-trimethylphenol, N-acetylserotonin, and 5-hydroxyindole exhibit neuroprotective effects without any estrogenicity. Comparing various natural and synthetic mono- and polyphenolic compounds, no correlation between their antioxidant cytoprotective effect and their estrogenic potency can be seen. These results call into question the idea of a general correlation between the intended pharmacological effects of estrogens and phenolic compounds and their effect on estrogen receptor-dependent pathways. Furthermore, they may open the door toward the rational design of neuroprotective antioxidants with decreased hormonal side effects.
引用
收藏
页码:8867 / 8872
页数:6
相关论文
共 67 条
  • [1] Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition
    Agullo, G
    GametPayrastre, L
    Manenti, S
    Viala, C
    Remesy, C
    Chap, H
    Payrastre, B
    [J]. BIOCHEMICAL PHARMACOLOGY, 1997, 53 (11) : 1649 - 1657
  • [2] AGING, ENERGY, AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISEASES
    BEAL, MF
    [J]. ANNALS OF NEUROLOGY, 1995, 38 (03) : 357 - 366
  • [3] GENE-REGULATION BY STEROID-HORMONES
    BEATO, M
    [J]. CELL, 1989, 56 (03) : 335 - 344
  • [4] Alzheimer's disease and oxidative stress: Implications for novel therapeutic approaches
    Behl, C
    [J]. PROGRESS IN NEUROBIOLOGY, 1999, 57 (03) : 301 - 323
  • [5] Neuroprotection against oxidative stress by estrogens: Structure-activity relationship
    Behl, C
    Skutella, T
    Lezoualch, F
    Post, A
    Widmann, M
    Newton, CJ
    Holsboer, F
    [J]. MOLECULAR PHARMACOLOGY, 1997, 51 (04) : 535 - 541
  • [6] 17-BETA ESTRADIOL PROTECTS NEURONS FROM OXIDATIVE STRESS-INDUCED CELL-DEATH IN-VITRO
    BEHL, C
    WIDMANN, M
    TRAPP, T
    HOLSBOER, F
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 216 (02) : 473 - 482
  • [7] A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE
    BOUSSIF, O
    LEZOUALCH, F
    ZANTA, MA
    MERGNY, MD
    SCHERMAN, D
    DEMENEIX, B
    BEHR, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) : 7297 - 7301
  • [8] Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
  • [9] Serotonin in the regulation of brain microcirculation
    Cohen, Z
    Bonvento, G
    Lacombe, P
    Hamel, E
    [J]. PROGRESS IN NEUROBIOLOGY, 1996, 50 (04) : 335 - +
  • [10] Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer
    Colditz, GA
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (11): : 814 - 823